FIELD: medicine, pharmaceutics.
SUBSTANCE: invention refers to 1-(4-{1-[(E)-4-cyclohexyl-3-trifluoromethylbenzyloxyimino]ethyl}-2-ethyl benzyl)azetidine-3-carboxylic acid hemifumarate salt, as well as to its polymorphous forms, pharmaceutical compositions inhibiting EDG receptors containing the above salt and its polymorphs.
EFFECT: what is prepared is the novel 1-(4-{1-[(E)-4-cyclohexyl-3-trifluoromethylbenzyloxyimino]ethyl}-2-ethyl benzyl)azetidine-3-carboxylic acid salt and the based pharmaceutical composition that can find application in treating the lymphocyte-mediated conditions.
22 cl, 9 dwg, 3 tbl, 6 ex
| Title |
Year |
Author |
Number |
| SPHINGOSINE-1-PHOSPHATE (S1P) RECEPTOR MODULATORS AND USING THEM FOR TREATING MUSCULAR TISSUE INFLAMMATION |
2009 |
- Sajid Sokhajl Akhmed
- Marko Londej
- Timoti Rajt
- Peter Gergeli
|
RU2521286C2 |
| CRYSTALLINE FORMS OF 3-(2,6-DICHLORO-3,5-DIMETHOXYPHENYL)-1-{ 6-[4-(4-ETHYLPIPERAZIN-1-YL)-PHENYLAMINO]-PYRIMIDIN-4-YL} -1-METHYLUREA AND ITS FRACTIONS |
2010 |
- Jerg Bergkhauzen
- Prasad Kotesvara Kapa
- Dzhozef Makkenna
- Dzhoehl Slejd
- Rejann Vu
- Chzhehnmin Du
- Frank Shtovasser
|
RU2572848C2 |
| CRYSTALLINE FUMARATE SALT OF (S)-[3,4-DIFLUORO-2-(2-FLUORO-4-IODOPHENYLAMINO)PHENYL][3-HYDROXY-3-(PIPERIDINE-2-YL)AZETIDINE-1-YL]METHANONE |
2016 |
|
RU2762181C2 |
| IDENTIFICATION OF PATIENTS' REACTION TO ADMINISTRATION OF S1P RECEPTOR MODULATOR |
2013 |
- Borell, Hubert
- Gardin, Anne
- Jin, Yi
- Legangneux, Eric
- Ufer, Mike
|
RU2785736C2 |
| CRYSTALLINE FORMS OF [(S)-1-CARBAMOYL-2-(PHENYLPYRIMIDIN-2-YLAMINO)ETHYL]AMIDE 2-(2-METHYLAMINOPYRIMIDIN-4-YL)-1H-INDOLE-5-CARBONIC ACID |
2012 |
- Rittseler Olaf
- Monikke Mandi
- Billen Gyunter
- Baumgartner Bruno
- Brekelmann Martin
- Nagel Norbert
|
RU2631320C2 |
| CRYSTALLINE MODIFICATIONS OF 3-(1H-INDOL-3-YL)-4-(4-METHYLPIPERAZIN-1-YL)QUINAZOLIN-4-YL)PYRROL-2,5-DIONE |
2007 |
- Karpinski P'Otr
- Monn'E Stefani
- Ndz'E Ehl'Jas
- Papoutsakis Dimitris
- Satton Pol Allen
|
RU2481341C2 |
| 1-[2-(4-BENZYL-4-HYDROXYPIPERIDIN-1-YL)-ETHYL]-3-(2-METHYLQUINOLIN-4-YL)-UREA IN CRYSTALLINE SULPHATE FORM |
2005 |
- Rede Stefan
- Bukhmann Shtefan
- Bonar Zhan-Mishel'
- Vuane Bertran
|
RU2397978C2 |
| SYNTHESIS OF N-(4-FLUOROBENZYL)-N-(1-METHYLPIPERIDIN-4-YL)-N'-(4-(2-METHYLPROPYLOXY)PHENYLMETHYL)CARBAMIDE, AS WELL AS TARTRATE AND CRYSTALLINE FORMS THEREOF |
2005 |
- Tjugesen Mikkel'
- Shlinger Natali
- Tol'F Bo-Ragnar
- Andersson Karl-Magnus A.
- Blatter Fritts
- Bergkhauzen Jorg
|
RU2417986C2 |
| POLYMORPHIC FORM OF [5-FLUORINE-3-({ 2-[(4-FLUOROBENZENE) SULFONYL]PYRIDINE-3-YL} METHYL)-2-METHYLINDOLE-1-YL]-ACETIC ACID |
2015 |
- Grosse-Sender Katya
- Khilfiker Rolf
|
RU2751319C2 |
| IMMUNOSUPPRESSIVE COMPOUNDS AND COMPOSITIONS |
2004 |
- Pan' Shifen
- Gao Vehn'Tsi
- Grej Natanaehl' S.
- Mi Juan'
- I. Fan'
|
RU2405768C2 |
